Summary. Two transplantable, highly immunogenic syngeneic C57BL fibrosarcomas, FS1 and FS6, were shown to have tumour-specific rejection antigens, as shown by excision of the primary tumours and i.p. or i.m. injection of graded doses of the specific and unrelated tumour cells. I.p. challenge with tumour cells induced a large and relatively long-lasting increase in numbers of peritoneal leucocytes. Macrophage monolayers prepared from such exudates were, in general, non-specifically cytotoxic, though occasional specific cytotoxicity was detected. T lymphocytes isolated from exudates were shown to kill in a specific manner. When immunized mice were challenged with the specific tumour cells to elicit large numbers of peritoneal cytotoxic cells, and with graded doses of the non-cross-reacting tumour cells at the same time or at various times thereafter, growth of the non-related tumours occurred in all cases and only the specific tumour was rejected. Moreover, Winn tests, in which the inflammatory cells were mixed with unrelated tumour cells and implanted i.m., did not delay tumour growth. The relevance of these findings to the role of macrophages and lymphocytes in syngeneic tumour rejection is discussed.
DURING the last decade, strong evidence has been presented that lymphocytes, macrophages and more recently, natural killer cells (NK cells) may be involved in host anti-tumour defence mechanisms. All 3 can be demonstrated to exert potent in vitro cytotoxicity against neoplastic or transformed cells, and this forms the basic tenet for postulating that these cells may be involved in surveillance. The major difference between lymphocyte-mediated cytotoxicity and macrophage-mediated cytotoxicity is in their specificity of action. Cytotoxic lymphocytes, elicited by exposure of an animal to a particular antigen, kill only tumour cells bearing the antigen used for sensitization (Cerottini & Brunner, 1974) ; whereas cytotoxic macrophages, however induced, generally damage any tumour cells in vitro (Evans & Alexander, 1976) . Thus, macrophage cytotoxicity is often non-specific in that it extends to a wide range of target cells, although it can show some measure of selectivity in that tumour cells are affected more than are normal cells (Hibbs, 1974) . Cytotoxic macrophages can be elicited in the absence of T lymphocytes in vitro (Alexander & Evans, 1971) as well as in T-lymphocytedepleted mice (Kaplan et al., 1974; Ghaffer et al., 1975; Pimm & Baldwin, 1975) . These findings, together with the abundant evidence that bacterial-and parasite-injected animals (Hibbs, 1976) from which cytotoxic macrophages can be obtained, also show increased resistance to tumour challenge, strongly support the concept of macrophage involvement in surveillance.
In the experiments described below, both macrophage-and lymphocyte-mediated cytotoxicity were (Evans & Alexander, 1976) refers to the extent of damage or disturbance of function induced in a target cell after interaction with an effector cell, and embraces both growth inhibition and lysis as measures of cytotoxicity.
Cytoxicity Assays.-Two assays were run in parallel:
(a) Growth Inhibition. Macrophage monolayers were challenged with 5 x 104 FS1 or FS6 cells in 1.5 ml of growth medium. After 72 h at 37°C, 2 x 107 sheep red blood cells (SRBC) coated with mouse-anti-SRBC serum (EA) in 0-1 ml were added and incubated for a further 30 min. The medium was then gently removed and replaced with 1 ml of 0.1% trypsin, which after 20 min at 37°C detached adherent tumour cells which were then counted in a haemocytometer. Any macrophages present could be readily distinguished by the presence of phagocytosed EA. Growth inhibition was calculated from not respond to these stumuli. Over a period of 21 days after i.p. challenge, it was seen that the total number of cells peaked around Days 5 to 7, but was still somewhat elevated on Day 21. Fig. 1 (a and b) summarizes representative experimental data on macrophagemediated cytotoxicity for selected times over a 12-day period . Fig l(a) shows growth inhibition and lysis induced by macrophage monolayers prepared from exudates from mice immunized and challenged with FS6 cells. It is seen that cytotoxicity was mainly non-specific. Both FS6 and FS1 cells were inhibited in their growth or were lysed, although not infrequently it was more potent towards the specific target cells. By Day 7 after challenge of mice the cytotoxicity displayed by the adherent exudate cells was occasionally specific. At this time strong growth inhibition and lysis was exerted against FS6 cells, whereas against FS1 cells there was only weak growth inhibition. Fig l(b) shows the cytotoxicity of macrophages from mice immunized and challenged with FSI cells. A similar type of reaction was found, except that macrophage monolayers were almost invariably non-specifically cytotoxic. Peritoneal macrophages from unchallenged, immunized mice, or from immunized mice challenged with the non-cross-reacting tumours, or thioglycollate medium, were neither growth inhibitory nor lytic. Both anti-FSI and anti-FS6 macrophages were also cytotoxic towards two other sygeneic fibrosarcoma cell lines, 2 allogeneic fibrosarcoma cell lines and one allogeneic lymphoma cell line (data not given). Fig. 2 (a and b) shows that immune PEC conferred protection on normal mice towards the specific immunizing tumour cells but there was no significant decrease in either the rate of emergence of unrelated tumours or in their rate of progression.
DISCUSSION
The purpose of the above study was two-fold: firstly, to find the best method for elicitation of cytotoxic cells in tumourimmunized mice; and secondly, to attempt to correlate in vitro anti-tumour activity with specific rejection seen in the immunized mice (See Table I ). It was found that elicitation of cytotoxicity was tumour-specific, in that injection of the unrelated tumour cells did not result in the appearance of cytotoxic macrophages or lymphocytes, even though inflammation was induced. Apart from demonstrating that the specific antigen was required to elicit cytotoxic cells, the experiments showed that the non-specific induction of an inflammatory response did not draw cytotoxic cells into the peritoneal cavity, i.e. induction of cytotoxicity was a localized event. Two cytotoxic cell types, macrophages and T lymphocytes, were identified. Both are regarded as essential components in both syngeneic tumour rejection and allograft rejection (Cerotinni and Brunner, 1974) whether alone or in combination with humoral factors, the macrophages perhaps amplifying T-cell cytotoxicity (Lohmann-Mathes, 1976) . However, in vitro data indicated that while T-cell killing was always immunologically specific, macrophage cytotoxicity was in general non-specific. Specifically cytotoxic T cells have also been demonstrated in the peritoneal cavity during BCG-induced rejection of FS6 or FS1 (Parr et al., 1977) . As indicated previously (Evans & Alexander, 1972a) macrophages recovered from the peritoneal cavity of lymphoma-immunized syngeneic mice soon after i.p. challenge were non-specifically cytotoxic, but this disappeared in time and, thereafter,macrophage cytoxicity was specific for the tumour cells used for immunization. In the case of the FS6 and FS1 fibrosarcomas, the kinetics of production of cytotoxic macrophages were somewhat different from the lymphoma situation, in that only occasionally were specifically cytotoxic macrophages seen, and in (Evans & 1972b) . The reason for this probably lies in the nature of cells. The recognition mechanis in this form of non-specific ir mediated cytotoxicity is ni Although immunogenicity stuc fibrosarcomas showed that in vi was wholly specific (Table I) it that cytotoxic macrophages we ing some kind of shared cr tumour-associated antigens in been shown in certain oth systems (Baldwin & Embete Fritze et al., 1975 (Fig. 2) . These results agree with other reports which also showed no evidence for such an effect (Klein & Klein, 1954; Zbar et al., 1970) . The latter report demonstrated that a guinea-pig hepatoma (Line 7) induced specific immunity after its excision, and failed to protect against an unrelated tumour, the Line 1 hepatoma. Our findings would, however, appear to differ from the several reports, summarized in an excellent review by Hibbs (1976) possible that, under these circumstances, macrophage cytotoxicity is maintained for a much longer time in vivo, and is therefore more effective in controlling could not be tumour growth. Other possible reasons pared with for the failure to demonstrate nonlymphoma-specific resistance in our system are (1) Alexander, that the cytotoxicity was blocked or discrepancy inhibited in some way and was unable to the tumour express itself in vivo, and (2) that perhaps in involved the in vitro cytotoxic effects were exagiacrophage-gerated because of the prevalent cultural ot known. conditions. This second possibility, if not lies of these correct, is intrinsically of interest in ivo rejection that it raises an issue, muted previously, t is possible concerning the relationship between growth re recognis-inhibition and lysis: whether they are oss-reacting reactions with similar or different pathvitro, as has ways (Evans & Alexander, 1976) . Macroier tumour phage cytotoxicity was assessed by growth -ton, 1974; inhibition and lytic assays, because of the overall evidence that macrophages may express a spectrum of cytotoxic reactivity from transient growth inhibition to irreversible lysis. In the event, this approach was justified because, when lysis was detectable, growth inhibition was unfailingly very strong, but the reverse was not necessarily true. The crux of the problem seems to lie in the importance of macrophage-mediated growth inhibition, whether under some conditions it leads to lysis directly, or whether its purpose is to predispose the cells to attack by some other effector mechanism, such as lysis by T lymphocytes. The conclusion reached from these results is that specific rejection of FS1 and FS6 fibrosarcomas was mediated by T lymphocytes, and possibly assisted by macrophages. We found no evidence that non-specific macrophage cytotoxicity was operational in vivo, as measured by failure of immunized mice to reject the unrelated tumour cells, even though in vitro macrophages were potently cytotoxic. The suggestion is that, while non-specific macrophage cytotoxicity may play a role in surveillance by inhibiting the emergence of neoplasms, it may fail to exert an effect against tumour cells which are already relatively fast dividing.
